Ginkgo Bioworks Holdings (DNA) Free Cash Flow (QoQ) (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) Free Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Ginkgo Bioworks Holdings | 440.77 Mn | 296.91 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.82% |
| Dec 31, 2025 | -21.82% |
| Sep 30, 2025 | 5.75% |
| Jun 30, 2025 | 17.55% |
| Mar 31, 2025 | 51.93% |
| Dec 31, 2024 | -1.86% |
| Sep 30, 2024 | -31.02% |
| Jun 30, 2024 | 18.19% |
| Mar 31, 2024 | -0.07% |
| Dec 31, 2023 | -121.42% |
| Sep 30, 2023 | 50.26% |
| Jun 30, 2023 | 20.87% |
| Mar 31, 2023 | 25.05% |
| Dec 31, 2022 | -286.91% |
| Sep 30, 2022 | 62.82% |
| Jun 30, 2022 | -476.95% |
| Mar 31, 2022 | 84.58% |
| Dec 31, 2021 | -974.42% |
| Sep 30, 2021 | 81.89% |
| Jun 30, 2021 | 15.87% |